Market Movers Today: Micron Technology, Inc. (MU), Cogentix Medical Inc. (CGNT), BlueLinx Holdings Inc. (BXC), and More
Micron Technology Inc. MU, +10.22% shares surged Monday after one analyst nearly doubled his price target on the stock.
Posts Tagged ‘Anthera Pharmaceuticals Inc (ANTH)’
13G Filing: Sabby Capital and Anthera Pharmaceuticals Inc (ANTH)
Sabby Healthcare Master Fund, Ltd | 0 | 551,250 | 0 | 551,250 | 551,250 | 3.98 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 03674U300 1.
Anthera Pharmaceuticals Inc (ANTH) Looks Good For A Recovery
Anthera Pharmaceuticals Inc (NASDAQ:ANTH) is heading into the close of the year more than 60% down on its early week market cap, on the release of some seemingly disappointing...
Biotech Movers And Shakers: Cascadian Therapeutics Inc (USA) (CASC) And Anthera Pharmaceuticals Inc (ANTH)
Another day done in biotech, and we’re fast closing in on the end of the week.
Here’s Our Take On The Latest Anthera Pharmaceuticals Inc (ANTH) Numbers
While the wider biotech space was enjoying something of a unexpected return to positive sentiment on Wednesday and Thursday, buoyed by the lifting of the potential investigations...
Here Are Two Biotechs With Catalysts Next Week
It’s going to be a busy quarter for a few companies in the biotech space, with a number of catalysts slated for the next month or so.
Anthera Pharmaceuticals Inc (ANTH): Biotechnology Value Fund Reports 9.99% Stake
Mark Lampert's Biotechnology Value Fund recently filed a Form 13G with the SEC, in which it reported acquiring 4.58 million shares of Anthera Pharmaceuticals Inc (NASDAQ:ANTH...
Weak Earnings And Terminated Partnerships, Oh My! Tuesday’s Hottest Stocks
Unilife Corp (NASDAQ:UNIS) and Anthera Pharmaceuticals Inc (NASDAQ:ANTH) were among the stocks losing ground early this morning, though one of them has quickly rebounded to turn...
Should You Buy Anthera Pharmaceuticals Inc (ANTH) Following Public Offering Of Common Shares?
In an effort to generate funds for clinical research and development and other general corporate purposes, Anthera Pharmaceuticals Inc (NASDAQ:ANTH) announced earlier today ...
PowerSecure International Inc. (POWR), Anthera Pharmaceuticals Inc (ANTH): Broadfin Capital and Becker Drapkin Management’s Recent Bullish Moves
Last Friday, Kevin Kotler’s Broadfin Capital disclosed a marked increase (of almost 70%) in its exposure to Anthera Pharmaceuticals Inc (NASDAQ:ANTH).
Tang Capital Management Discloses Moves into La Jolla Pharmaceutical Company (LJPCD), Vanda Pharmaceuticals Inc. (VNDA), Mirati Therapeutics Inc. (MRTX) & Others
Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio.
Insider Trading: Samuel Isaly’s Orbimed Advisors is Selling $ANTH
Samuel Isaly’s Orbimed Advisors filed for its recent insider sales in Anthera Pharmaceuticals Inc (ANTH) on November 18th.
Hedge Fund Resource Center
